𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab in the treatment of dermatomyositis: An open-label pilot study

✍ Scribed by Todd D. Levine

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
93 KB
Volume
52
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pilot open-label study of nefazodone in
Pilot open-label study of nefazodone in panic disorder
✍ Alexander Bystritsky; Richard Rosen; Rita Suri; Tanya Vapnik πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 2 views

Ten patients meeting DSM-IV criteria for non-comorbid panic disorder or panic disorder with agoraphobia were treated in a 12-week open-label, flexible dosage trial of nefazodone. Dosages ranged from 50 to 400 mg per day. Clinical assessment utilized several recently developed scales of panic disorde

Ipsapirone in the treatment of bulimia n
Ipsapirone in the treatment of bulimia nervosa: An open pilot study
✍ Geretsegger, Christian ;Greimel, Karoline V. ;Roed, Llona S. ;Hesselink, Jan M. πŸ“‚ Article πŸ“… 1995 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 326 KB πŸ‘ 2 views

Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,\* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge ea